Antiretroviral therapies (ART) have diverse effects on adipose tissue biology, clinically observed through changes in weight and fat distribution with ART initiation or switch. The mechanisms that underlie these changes are incompletely understood, especially for newer classes of ART such as integrase-inhibitors (INSTIs). Thus, we sought to examine the effects of modern ART regimens on aspects of adipocyte biology related to weight gain
We established cultures of human preadipocytes and newly differentiated adipocytes from HIV uninfected individuals to examine effects of an INSTI; Dolutegravir (DTG), compared to a protease inhibitor; Darunavir (DRV). For experiments on mature adipocytes, cells were differentiated for 7 days using an adipogenic medium. Adipocytes were switched to a maintenance media and treated with DMSO (Control), DTG, 3.1?g/mL, or DRV, 11.8?M at day 7. After 7 days, cells were maintained or switched to other ART until day 21. Experiments examining preadipocyte responses and effects on adipogenesis initiated treatment during proliferation of precursors, and continued throughout differentiation. Triglyceride content, lactate production and lipolysis were assessed by enzymatic assay and normalized to DNA content. Adipogenic gene expression was assessed using qPCR, and adipokine secretion was determined with ELISA. Oxygen consumption (OCR) and extracellular acidification rates (ECAR) were determined using Seahorse.
Exposure to DTG and DRV did not alter cell viability regardless of treatment regimen. Exposure to DTG increased lactate production between 1.3 and 2-fold in both preadipocytes and adipocytes (p<0.05) and this increase was reversed in adipocytes when switched to DRV (Image). Accordingly, both basal and maximal OCR were decreased ~15% in cells treated with DTG with corresponding increases in ECAR. DTG exposure in preadipocytes prior to and during differentiation increased expression of PPAR?, a late adipogenic marker (1.5 fold, p<0.05) but also suppressed triglyceride accumulation without altering rates of lipolysis. Additionally, cells treated with DTG decreased secretion of leptin and adiponectin.
The observed increases in lactate production and decreased oxygen consumption in preadipocytes and adipocytes treated with DTG indicate impairments in mitochondrial function. These alterations in metabolism combined with suppression of key regulatory adipokines may help explain the increased weight gain observed in individuals taking INSTIs.